Key statistics
As of last trade Vertex Pharmaceuticals Inc (VX1:DUS) traded at 429.25, -11.70% below its 52-week high of 486.10, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 429.55 |
---|---|
High | 429.55 |
Low | 428.75 |
Bid | 431.40 |
Offer | 433.95 |
Previous close | 429.80 |
Average volume | 88.89 |
---|---|
Shares outstanding | 257.53m |
Free float | 257.33m |
P/E (TTM) | -- |
Market cap | 115.98bn USD |
EPS (TTM) | -1.99 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 11:30 GMT.
More ▼
Press releases
- Vertex Reports Third Quarter 2024 Financial Results
- Vertex to Participate in Upcoming November Investor Conferences
- Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress
- Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting
- Vertex to Announce Third Quarter 2024 Financial Results on November 4th
- Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference
More ▼